Listed

Research Solutions, Inc.: Form 10-Q for the period ended Mar 31, 2020

Filed with the SEC on May 14, 2020 and accepted by EDGAR at May 14, 2020, 20:02 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-01-01 to 2020-03-31$8.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-07-01 to 2020-03-31$23.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-01-01 to 2020-03-31$5.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2019-07-01 to 2020-03-31$16.0mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2020-01-01 to 2020-03-31$2.5mus-gaap:GrossProfit
Gross profit9 months2019-07-01 to 2020-03-31$7.1mus-gaap:GrossProfit
Selling, general and administrative3 months2020-01-01 to 2020-03-31$2.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2019-07-01 to 2020-03-31$8.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-01-01 to 2020-03-31−$11.2kus-gaap:OperatingIncomeLoss
Operating income9 months2019-07-01 to 2020-03-31−$847.0kus-gaap:OperatingIncomeLoss
Income tax3 months2020-01-01 to 2020-03-31$561us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-07-01 to 2020-03-31$7.9kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-01-01 to 2020-03-31$11.9kus-gaap:NetIncomeLoss
Net income9 months2019-07-01 to 2020-03-31−$661.7kus-gaap:NetIncomeLoss
Diluted EPS3 months2020-01-01 to 2020-03-31$0.00us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-07-01 to 2020-03-31−$0.03us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-01-01 to 2020-03-31$0.00us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-07-01 to 2020-03-31−$0.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-01-01 to 2020-03-3125,717,403 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-07-01 to 2020-03-3124,411,888 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-07-01 to 2020-03-31$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-07-01 to 2020-03-31$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2019-07-01 to 2020-03-31$268.5kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-03-31$8.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-03-31$14.2mus-gaap:AssetsCurrent
Total assetsAt period end2020-03-31$14.4mus-gaap:Assets
Current liabilitiesAt period end2020-03-31$9.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-03-31$9.6mus-gaap:Liabilities
Shareholders' equityAt period end2020-03-31$4.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-20-061571. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.